...PIK3CA gene in 195, 71 and 68 adenocarcinomas, respectively.,EGFR, HER2, KRAS and MET mutations were found in 103 (49%),...
...PIK3CA gene mutations in pts with advanced NSCLC who had been treated with gefitinib or erlotinib after failure of 1 or ...
...PIK3CA mutations were associated with pAKT+ status only in 2 pts. In all 5 tumors with PIK3CA mutations, a PTEN+ status ...
...PIK3CA mutation status was evaluated by sequencing of PIK3CA exons 9 and 20 using PCR amplification and direct sequencin...
...PIK3CA and exons 5-8 of TP53, and at baseline and day 15 for Ki67, phospho-Akt S473, phospho-S6, PTEN, CyclinD1, ER, PR,...
...PIK3CA, AKT3, PTEN, 1q25 and the centromeres (cen) of chromosomes 3, 10, and 17 with response in metastatic ERBB2-amplif...
...PIK3CA, BRAF, KRAS, and p53. Two of these mutations are now known to have direct clinical relevance; mutations in the EG...
...PIK3CA mutations are commonly associated with most breast cancer subtypes. More recently PIK3CA mutations have been show...
...PIK3CA. Here we show that mutant PIK3CA-expressing breast cancer cells have greater sensitivity to aspirin-mediated grow...
...PIK3CA) genes alone might not be sufficient, and thus, new predictive and prognostic biomarkers are urgently required. T...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
